27 related articles for article (PubMed ID: 11956327)
1. Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.
Alfano M; Sidenius N; Panzeri B; Blasi F; Poli G
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8862-7. PubMed ID: 12084931
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation.
Veljkovic DK; Rivard GE; Diamandis M; Blavignac J; Cramer-Bordé EM; Hayward CP
Blood; 2009 Feb; 113(7):1535-42. PubMed ID: 19029443
[TBL] [Abstract][Full Text] [Related]
3. Compared to preoperative plasma levels post-operative urokinase-type plasminogen activator-1 levels are persistently elevated for 6 weeks after minimally invasive colorectal resection.
Shantha Kumara H; Poppy A; Gamage DN; Mitra N; Yan X; Hedjar Y; Cekic V; Whelan RL
J Gastrointest Oncol; 2023 Feb; 14(1):187-197. PubMed ID: 36915462
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase CK2 inhibition suppresses neointima formation via a proline-rich homeodomain-dependent mechanism.
Wadey KS; Brown BA; Sala-Newby GB; Jayaraman PS; Gaston K; George SJ
Vascul Pharmacol; 2017 Dec; 99():34-44. PubMed ID: 28927755
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.
Sisson TH; Nguyen MH; Yu B; Novak ML; Simon RH; Koh TJ
Blood; 2009 Dec; 114(24):5052-61. PubMed ID: 19812386
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.
Ustach CV; Kim HR
Mol Cell Biol; 2005 Jul; 25(14):6279-88. PubMed ID: 15988036
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk of anosmin-1, the protein implicated in X-linked Kallmann's syndrome, with heparan sulphate and urokinase-type plasminogen activator.
Hu Y; González-Martínez D; Kim SH; Bouloux PM
Biochem J; 2004 Dec; 384(Pt 3):495-505. PubMed ID: 15324302
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia pneumoniae decreases smooth muscle cell proliferation through induction of prostaglandin E2 synthesis.
Rödel J; Prochnau D; Prager K; Baumert J; Schmidt KH; Straube E
Infect Immun; 2004 Aug; 72(8):4900-4. PubMed ID: 15271958
[TBL] [Abstract][Full Text] [Related]
9. Regulation and role of urokinase plasminogen activator in vascular remodelling.
Tkachuk V; Stepanova V; Little PJ; Bobik A
Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):759-65. PubMed ID: 8911711
[TBL] [Abstract][Full Text] [Related]
10. Structure, function and antagonists of urokinase-type plasminogen activator.
Vincenza Carriero M; Franco P; Vocca I; Alfano D; Longanesi-Cattani I; Bifulco K; Mancini A; Caputi M; Stoppelli MP
Front Biosci (Landmark Ed); 2009 Jan; 14(10):3782-94. PubMed ID: 19273310
[TBL] [Abstract][Full Text] [Related]
11. The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells.
Padró T; Mesters RM; Dankbar B; Hintelmann H; Bieker R; Kiehl M; Berdel WE; Kienast J
J Cell Sci; 2002 May; 115(Pt 9):1961-71. PubMed ID: 11956327
[TBL] [Abstract][Full Text] [Related]
12. Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders.
Kanse SM; Benzakour O; Kanthou C; Kost C; Lijnen HR; Preissner KT
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2848-54. PubMed ID: 9409265
[TBL] [Abstract][Full Text] [Related]
13. Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells.
Herbert JM; Lamarche I; Carmeliet P
J Biol Chem; 1997 Sep; 272(38):23585-91. PubMed ID: 9295297
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
Reuning U; Bang NU
Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
